Improved Outcomes in Myelofibrosis after Allogeneic Stem-Cell Transplantation in the Era of Ruxolitinib Pretreatment and Intensified Conditioning Regimen—Single-Center AnalysisSigrid Machherndl‐Spandl, Veronika Buxhofer‐Ausch, Irene Straßl et al.|Cancers|2024Cited by 4
Rapid Hematological and Molecular Response to Pegylated Interferon in WHO-Defined Pre-Fibrotic MyelofibrosisSigrid Machherndl‐Spandl, Veronika Buxhofer‐Ausch, Marcel Kiehberger et al.|Cancers|2025Cited by 1